Nanosonics Limited (ASX:NAN)

Michael Kavanagh
CEO, President & MD
Market Cap (AUD): 1.03B
Sector: Health Care
Last Trade (AUD): 3.36 -0.06 (-1.75%)
Tab Bar

1. About

Nanosonics Limited (ASX:NAN) is an innovator in infection prevention. The Company's unique, automated trophon EPR high level disinfection device has paved the way around the world in setting a new standard of care in ultrasound probe disinfection practices.

trophon is a global solution for reducing cross contamination between patients and reducing the spread of Healthcare Acquired Infections (HAIs).

With a growing trend towards stricter ultrasound probe reprocessing guidelines, traditional systems have been falling behind in their ability to meet today's demanding requirements. The cutting edge technology used in trophon has disrupted the disinfection market and was the first major innovation in ultrasound probe HLD in more than 20 years.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk